The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Ovarian Cancer Screen 50 Tissue Microarray - LS-SOVCA50

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SOVCA50
Product Name:	Ovarian Cancer Screen 50
Description:	Various ovarian diseases (ovarian cancer progression) with stage/grade
Format:	FFPE
Category:	Human Tumor Progression
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1 mm
Core Thickness:	5 µm
Cases:	100
Cores:	100
Slides Per Set:	1

LS-SOVCA50 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10
A	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
B	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
C	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
D	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
E	Ova	Ova	Ova	Ova	Ova	Mes	Mes	Gro	Gro	Gro
F	Gro	Gro	Gro	Plc	Plc	Ova	Ova	Ova	Ova	Ova
G	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
H	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
I	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
J	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Greater omentum (Gro); Mesentery (Mes); Ovary (Ova); Peritoneal cavity (Plc);

LS-SOVCA50 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade	Tumor Stage
1	A1	Human	F	65 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T1N0M0	1	I
1	A2	Human	F	38 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T3cN1M1	1	IV
1	A3	Human	F	51 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T3cN1M0	1	IIIC
1	A4	Human	F	22 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T2bN0M0	1	IIB
1	A5	Human	F	48 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T1N0M0	1	I
1	A6	Human	F	26 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T3cN1M0	1	IIIC
1	A7	Human	F	25 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T1N0M0	1	I
1	A8	Human	F	50 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T2N0M0	1	II
1	A9	Human	F	26 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T1cN0M0	1	IC
1	A10	Human	F	47 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T1N0M0	1	I
1	B1	Human	F	58 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1N0M0	2	I
1	B2	Human	F	57 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T1cN0M0	2	IC
1	B3	Human	F	51 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1aN0M0	2	IA
1	B4	Human	F	52 y	Ovary (Ova)	Cystadenocarcinoma, Papillary and serous	Malignant	T2N0M0	2	II
1	B5	Human	F	54 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T3cN1M0	2	IIIC
1	B6	Human	F	33 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1N0M0	2	I
1	B7	Human	F	56 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T2N0M0	2	II
1	B8	Human	F	41 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1N0M0	2	I
1	B9	Human	F	50 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1N0M0	2	I
1	B10	Human	F	46 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T2cN1M0	2	IIIC
1	C1	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3cN1M0	2-3	IIIC
1	C2	Human	F	75 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	2	II
1	C3	Human	F	54 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3cN0M0	2	IIIC
1	C4	Human	F	49 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T2N0M0	2	II
1	C5	Human	F	46 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T3aN1M0	2-3	IIIC
1	C6	Human	F	52 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	3	II
1	C7	Human	F	47 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1cN0M0	3	IC
1	C8	Human	F	34 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1bN0M0	1	IB
1	C9	Human	F	63 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1aN0M0	1	IA
1	C10	Human	F	69 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1bN0M0	1	IB
1	D1	Human	F	55 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T1N0M0		I
1	D2	Human	F	55 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T1N0M0		I
1	D3	Human	F	47 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T2aN0M0		IIA
1	D4	Human	F	53 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T2aN0M0		IIA
1	D5	Human	F	50 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T3bN1M0		IIIC
1	D6	Human	F	54 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T1bN0M0		IB
1	D7	Human	F	43 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T1cN0M0		IC
1	D8	Human	F	41 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T1aN0M0		IA
1	D9	Human	F	50 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T1bN0M0		IB
1	D10	Human	F	46 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T2N0M0		II
1	E1	Human	F	51 y	Ovary (Ova)	Transitional cell carcinoma	Malignant	T1bN0M0	2	IB
1	E2	Human	F	39 y	Ovary (Ova)	Transitional cell carcinoma	Malignant	T1aN0M0	2	IA
1	E3	Human	F	38 y	Ovary (Ova)	Transitional cell carcinoma	Malignant	T1N0M0	2	I
1	E4	Human	F	66 y	Ovary (Ova)	Transitional cell carcinoma with squamous metaplasia	Malignant	T1aN0M0	3	IA
1	E5	Human	F	53 y	Ovary (Ova)	Transitional cell carcinoma	Malignant	T1N0M0	2-3	I
1	E6	Human	F	47 y	Mesentery (Mes)	Metastasis from ovarian serous papillary cystadenocarcinoma	Metastatic		1
1	E7	Human	F	59 y	Mesentery (Mes)	Metastasis from ovarian serous papillary cystadenocarcinoma with calcification	Metastatic		1
1	E8	Human	F	28 y	Greater omentum (Gro)	Metastasis from ovarian serous papillary cystadenocarcinoma with calcification	Metastatic		1
1	E9	Human	F	65 y	Greater omentum (Gro)	Metastasis from ovarian serous papillary cystadenocarcinoma	Metastatic		2
1	E10	Human	F	64 y	Greater omentum (Gro)	Metastasis from ovarian serous adenocarcinoma	Metastatic		2
1	F1	Human	F	50 y	Greater omentum (Gro)	Metastasis from ovarian serous papillary cystadenocarcinoma	Metastatic		1
1	F2	Human	F	57 y	Greater omentum (Gro)	Metastasis from ovarian serous papillary cystadenocarcinoma	Metastatic		1
1	F3	Human	F	58 y	Greater omentum (Gro)	Metastasis from ovarian adenocarcinoma	Metastatic		3
1	F4	Human	F	47 y	Peritoneal cavity (Plc)	Metastasis from ovarian adenocarcinoma	Metastatic		3
1	F5	Human	F	49 y	Peritoneal cavity (Plc)	Metastasis from ovarian adenocarcinoma	Metastatic		3
1	F6	Human	F	34 y	Ovary (Ova)	Cystadenoma, Serous and papillary, Borderline	Tumor
1	F7	Human	F	28 y	Ovary (Ova)	Cystadenoma, Serous and papillary, Borderline	Tumor
1	F8	Human	F	22 y	Ovary (Ova)	Cystadenoma, Serous and papillary, Borderline	Tumor
1	F9	Human	F	53 y	Ovary (Ova)	Cystadenoma, Serous and papillary, Borderline	Tumor
1	F10	Human	F	69 y	Ovary (Ova)	Cystadenoma, Serous and papillary, Borderline	Tumor
1	G1	Human	F	50 y	Ovary (Ova)	Cystadenoma, Mucinous and papillary, Borderline	Tumor
1	G2	Human	F	37 y	Ovary (Ova)	Cystadenoma, Mucinous and papillary, Borderline	Tumor
1	G3	Human	F	62 y	Ovary (Ova)	Cystadenoma, Serous	Tumor
1	G4	Human	F	22 y	Ovary (Ova)	Cystadenoma, Serous	Tumor
1	G5	Human	F	49 y	Ovary (Ova)	Cystadenoma, Serous	Tumor
1	G6	Human	F	22 y	Ovary (Ova)	Cystadenoma, Serous	Tumor
1	G7	Human	F	16 y	Ovary (Ova)	Cystadenoma, Serous	Tumor
1	G8	Human	F	34 y	Ovary (Ova)	Cystadenoma, Serous	Tumor
1	G9	Human	F	19 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	G10	Human	F	18 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H1	Human	F	29 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H2	Human	F	32 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H3	Human	F	26 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H4	Human	F	70 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H5	Human	F	22 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H6	Human	F	33 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H7	Human	F	38 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H8	Human	F	51 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H9	Human	F	17 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	H10	Human	F	35 y	Ovary (Ova)	Cystadenoma, Mucinous	Tumor
1	I1	Human	F	30 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I2	Human	F	39 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I3	Human	F	29 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I4	Human	F	40 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I5	Human	F	40 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I6	Human	F	63 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I7	Human	F	45 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I8	Human	F	38 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I9	Human	F	53 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	I10	Human	F	42 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	J1	Human	F	57 y	Ovary (Ova)	Adjacent normal with mucinous cystadenocarcinoma	Diseased		2-3
1	J2	Human	F	38 y	Ovary (Ova)	Adjacent normal	Benign non-neoplastic
1	J3	Human	F	18 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J4	Human	F	20 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J5	Human	F	19 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J6	Human	F	15 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J7	Human	F	18 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J8	Human	F	21 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J9	Human	F	41 y	Ovary (Ova)	Normal	Benign non-neoplastic
1	J10	Human	F	27 y	Ovary (Ova)	Normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.